30 years ago, R-Biopharm was founded as a working group with only six employees. Today, it’s a leading developer of test solutions with more than 1,000 employees and subsidiaries and distributors all over the world. Take a look at our timeline and discover what happened on the way.
1988: Foundation of R-Biopharm as a subsidiary of Röhm GmbH
1991: Management buyout by Dr. Ralf M. Dreher
1993: Own sales network for Clinical Diagnostics
1996: Certification according to quality management standard ISO 9001
1998: Foundation of the first subsidiary (R-Biopharm Inc., USA)
2000: Worldwide exclusive distribution rights for the enzymatic test kits of Roche Diagnostics
2011: Acquisition of Rhône Diagnostics Technologies Ltd (90 %)
2002: Launch of the Gliadin kit (today’s bestseller). Foundation of the subsidiaries R-Biopharm Italia and R-Biopharm France
2005: Foundation of the subsidiary R-Biopharm Analysis Systems Trading Co. Ltd China
2006: Foundation of the subsidiaries R-Biopharm Brasil and R-Biopharm Latinoamérica
2007: Foundation of the subsidiaries R-Biopharm Australia and R-Biopharm España
2009: Move to the newly built headquarter at „An der neuen Bergstraße“
2010: Acquisition of Trilogy Analytical Laboratory, CTL & Ortholabor and Evomed Diagnostics AG
2011: Acquisition of CONGEN Biotechnolgie GmbH and humatrix AG. Foundation of Biotech-Park Pfungstadt GmbH & Co KG
2012: Acquisition of PROGEN Biotechnik GmbH and Bioserv Diagnostics GmbH
2013: Opening of Biotechpark Pfungstadt. New product field „Companion Diagnostics“ (Precision Medicine). Foundation of the subsidiary R-Biopharm Neugen Ptv. Ltd, India
2016: Acquisition of Europroxima
2017: Acquisition of Seramun Diagnostica GmbH
2018: R-Biopharm celebrates its 30th anniversary. Company founder Dr. Ralf M. Dreher hands over the management to his nephew Christian Dreher. Acquisition of Kem-En-Tec Diagnostics A/S.
